MHRA (Medicines and Healthcare products Regulatory Agency) formalises UK recall of ACS (Access CardioSystems) defibs:
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has echoed the worldwide recall of defibrillators manufactured by Access CardioSystems (ACS). The recall affects the Access AED, Access PAD, and Access ALS devices with serial numbers in the range 075180-084760. The MHRA reports two forms of potential failure, relating to the devices' inability to deliver more than one defibrillation shock and problems associated with the unexpected activation of the device (see Clinica No 1133, p 16). UK healthcare providers are urged to contact RL Dolby & Co (Stirling, Scotland), the UK distributor of the affected devices, for further details.
You may also be interested in...
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.
Indian drug makers appear confident of meeting both domestic and global requirements for hydroxychloroquine sulphate after India relaxed export curbs on the product, subject to strict monitoring, against the backdrop of requests from global heads of government for supplies of the potential treatment for COVID-19.
CEO breaks down to Scrip how the Hong Kong-based company managed its way through the coronavirus outbreak in China, saying improvisation was critical.